E7974
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for E7974, covering 2013-05-22 to 2015-07-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies [Phase 1]